Associated Papers
Saturation genome editing maps the functional spectrum of pathogenic VHL alleles.
Buckley M et al.
Nature Genetics, 2024
38969834 (PubMed )
Supplement: 41588_2024_1800_MOESM4_ESM.xlsx › ST1
Interaction between common variants of MDM2 and PPP1R13L and CD3EAP and TP53 SNPs in relation to lung cancer risk among Chinese.
Yin J et al.
Annals of Translational Medicine, 2020
Single-Nucleotide Polymorphism 309T>G in the MDM2 Promoter Determines Functional Outcome After Stroke.
Rodríguez C et al.
Stroke, 2018
Association between MDM2 SNP309, p53 Arg72Pro, and hepatocellular carcinoma risk: A MOOSE-compliant meta-analysis.
Duan X et al.
Medicine, 2017
Association of MDM2 promoter T309G polymorphism with oral cancer risk: A meta-analysis of 3,536 subjects.
Yang XI et al.
Molecular and Clinical Oncology, 2016
p53 Arg72Pro polymorphism and risk of basal cell carcinoma: a meta analysis.
Tian Y et al.
International Journal of Clinical and Experimental Medicine, 2015
Polymorphisms in the MDM2 promoter and risk of breast cancer: a case-control analysis in a Chinese population.
Ma H et al.
Cancer Letters, 2006
Select a paper to view details